What is the ROE (Return on Equity) of Cerus this year?
The ROE of Cerus this year is -0.71 undefined.
Cerus ROE 2024
Cerus ROE
-0.71
Ticker
CERS
ISIN
US1570851014
WKN
905249
In 2024, Cerus's return on equity (ROE) was -0.71, a 12.46% increase from the -0.63 ROE in the previous year.
Cerus Aktienanalyse
What does Cerus do?
Cerus Corporation is a biotechnology company specialized in the development and marketing of products for the processing and transfusion of blood products. The company was founded in 1991 and is headquartered in Concord, California. Cerus Corporation is listed on the NASDAQ stock exchange and employs approximately 450 employees worldwide. The history of Cerus Corporation began when its founder, Stephen Isaacs, received a blood transfusion and subsequently became infected with the Hepatitis B virus. This incident inspired him to start a company focusing on the development of technologies for the safe transfusion of blood products. In 1993, Cerus Corporation introduced its first product, the Intercept Blood System. This system utilized ultraviolet light and chemicals to deactivate pathogens such as viruses, bacteria, and parasites in blood. The business model of Cerus Corporation revolves around the development and distribution of products for medical needs. The company's focus is on the processing of blood products such as platelets, plasma, and red blood cells to reduce the risk of infectious diseases and other potentially harmful side effects in blood transfusions. Cerus also provides training and technical support for its products. Cerus Corporation has several divisions, including the Intercept Blood System, Blood Center Technology, and Innovative Technology. The Intercept Blood System division is the largest and most popular, offering products such as the Intercept Blood System for platelets and plasma, the Intercept Blood System for red blood cells, the Intercept Blood System for PAS (reduced volume blood bank) and the Intercept Blood System for Fresh Frozen Plasma. Cerus Corporation's Blood Center Technology division provides technologies and devices for blood banks and transfusion services, including transfusion safety systems and blood testing devices. The Innovative Technology division specializes in the development of new technologies and products. Another product of Cerus Corporation is INTERCEPT FDA Approved Plasma, which was approved by the US Food and Drug Administration (FDA) in 2018. The plasma is made from donated blood and processed using the INTERCEPT technology. The INTERCEPT technology decontaminates various blood components, increasing their safety in transfusions. Cerus Corporation has achieved significant success in the medical technology industry. Cerus Corporation's Intercept Blood System is approved in more than 25 countries and has helped save countless lives and prevent diseases for healthcare professionals and patients. The company has been recognized multiple times for its innovative products and services, including receiving the Gold Medal at the Edison Awards in 2017 and the Technology Pioneer Award from the World Economic Forum in 2016. In summary, Cerus Corporation is a successful biotechnology company that develops and distributes innovative technologies for the processing and transfusion of blood products. Through its technology and products, Cerus contributes to increasing the safety of blood transfusions by reducing the risk of infectious diseases and other potentially dangerous side effects. Cerus Corporation will continue to play an important role in the medical technology industry in the future. Cerus ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Cerus's Return on Equity (ROE)
Cerus's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Cerus's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Cerus's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Cerus’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Cerus Stock
How has the Return on Equity (ROE) of Cerus developed compared to the previous year?
The ROE of Cerus has increased by 12.46% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Cerus?
A high ROE indicates that Cerus generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Cerus?
A low ROE can indicate that Cerus is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Cerus affect the company?
A change in ROE (Return on Equity) of Cerus can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Cerus?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Cerus?
Some factors that can influence Cerus's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Cerus pay?
Over the past 12 months, Cerus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerus is expected to pay a dividend of 0 USD.
What is the dividend yield of Cerus?
The current dividend yield of Cerus is .
When does Cerus pay dividends?
Cerus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cerus?
Cerus paid dividends every year for the past 0 years.
What is the dividend of Cerus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cerus located?
Cerus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cerus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cerus from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.
When did Cerus pay the last dividend?
The last dividend was paid out on 7/1/2024.
What was the dividend of Cerus in the year 2023?
In the year 2023, Cerus distributed 0 USD as dividends.
In which currency does Cerus pay out the dividend?
The dividends of Cerus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cerus
Our stock analysis for Cerus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
